The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
Abstract
The androgen-androgen receptor (AR) signaling pathway plays a key role in proper development and function of male reproductive organs, such as prostate and epididymis, as well as nonreproductive organs, such as muscle, hair follicles, and brain. Abnormalities in the androgen-AR signaling pathway have been linked to diseases, such as male infertility, Kennedy’s disease, and prostate cancer. Regulation of AR activity can be achieved in several different ways: modulation of AR gene expression, androgen binding to AR, AR nuclear translocation, AR protein stability, and AR trans-activation. This review covers mechanisms implicated in the control of AR protein expression and degradation, and their potential linkage to the androgen-related diseases. A better understanding of such mechanisms may help us to design more effective androgens and antiandrogens to battle androgen-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., & Sigler, P. B. (1991) · Nature · doi:10.1038/352497a0 · Cited by 1,503
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., & Goodman, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210702 · Cited by 1,464
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Self-citationThe serum transport of steroid hormones
SIITERI, P. K., MURAI, J. T., RAYMOURE, W. J., KUHN, R. W., HAMMOND, G. L., & NISKER, J. A. (1982) · Proceedings of the 1981 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571138-8.50016-0 · Cited by 770
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523
Wallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394
Research works printed but not linked: 132
- Chang, 1988, Molecular cloning of the human and rat complementary DNA encoding androgen receptors., Science, 240, 324, 10.1126/science.3353726 · DOI · Paper page
- Lubahn, 1988, Cloning of the human androgen receptor complementary DNA and localization to the X chromosome., Science, 240, 327, 10.1126/science.3353727 · DOI · Paper page
- Trapman, 1988, Cloning, structure and expression of a cDNA encoding the human androgen receptor., Biochem Biophys Res Commun, 153, 241, 10.1016/S0006-291X(88)81214-2 · DOI · Paper page
- Chang, 1995, Androgen receptor: an overview., Crit Rev Eukaryotic Gene Express, 5, 97, 10.1615/CritRevEukarGeneExpr.v5.i2.10 · DOI · Paper page
- Roy, 1999, Regulation of androgen action., Vit Horm, 55, 309, 10.1016/S0083-6729(08)60938-3 · DOI · Paper page
- Miller, 1988, Molecular biology of steroid hormone synthesis., Endocr Rev, 9, 295, 10.1210/edrv-9-3-295 · DOI · Paper page
- Deslypere, 1992, Testosterone and 5-α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene., Mol Cell Endocrinol, 88, 15, 10.1016/0303-7207(92)90004-P · DOI · Paper page
- Quigley, 1995, Androgen receptor defects: historical, clinical, and molecular perspectives., Endocr Rev, 16, 271
- Avila, 2001, The androgen receptor (AR) in syndromes of androgen insenstivity and in prostate cancer., J Steroid Biochem Mol Biol, 76, 135, 10.1016/S0960-0760(00)00158-8 · DOI
- Migeon, 1981, Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse., Proc Natl Acad Sci USA, 78, 6339, 10.1073/pnas.78.10.6339 · DOI
- Brown, 1989, Androgen receptor locus on the human X chromosome: regional localization to Xq11–12 and description of a DNA polymorphism., Am J Hum Genet, 44, 264
- Yeh, 2002, Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen function., Proc Natl Acad Sci USA, 99, 13498, 10.1073/pnas.212474399 · DOI · Paper page
- Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members., Annu Rev Biochem, 63, 451, 10.1146/annurev.bi.63.070194.002315 · DOI · Paper page
- Edwards, 1999, Androgen receptor polymorphisms: association with prostate cancer risk, relapse, and overall survival., Int J Cancer, 84, 458, 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y · DOI
- Sleddins, 1993, Trinucleotide (GGN) repeat polymorphism in the androgen receptor gene., Hum Mol Genet, 2, 273
- Kazemi-Esfarjani, 1995, Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies., Hum Mol Genet, 4, 523, 10.1093/hmg/4.4.523 · DOI · Paper page
- Hsiao, 1999, The linkage of Kennedy’s Neuron Disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator., J Biol Chem, 274, 20229, 10.1074/jbc.274.29.20229 · DOI · Paper page
- Jenster, 1994, Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine stretch variation, and mutation of putative phosphorylation sites., Biochemistry, 33, 14064, 10.1021/bi00251a015 · DOI
- McPhaul, 1991, Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy., J Clin Invest, 87, 1413, 10.1172/JCI115147 · DOI
- Choong, 1996, Reduced androgen receptor gene expression with first exon CAG repeat expansion., Mol Endocrinol, 10, 1527
- La Spada, 1991, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy., Nature, 352, 77, 10.1038/352077a0 · DOI · Paper page
- Hakimi, 1997, Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer., Clin Cancer Res, 3, 1599
- Gao, 1996, Transcriptional activation and transient expression of the human androgen receptor., J Steroid Biochem Mol Biol, 59, 9, 10.1016/S0960-0760(96)00097-0 · DOI · Paper page
- Montgomery, 2001, The androgen receptor gene and its influence on the development and progression of prostate cancer., J Pathol, 195, 138, 10.1002/1096-9896(200109)195:2<138::AID-PATH961>3.0.CO;2-Y · DOI
- He, 2000, FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor., J Biol Chem, 275, 22986, 10.1074/jbc.M002807200 · DOI · Paper page
- He, 1999, Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain., J Biol Chem, 274, 37219, 10.1074/jbc.274.52.37219 · DOI · Paper page
- Ikonen, 1997, Interaction between the amino and carboxyl terminal regions of rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators., J Biol Chem, 272, 29821, 10.1074/jbc.272.47.29821 · DOI · Paper page
- Moilanen, 1999, A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins., J Biol Chem, 274, 3700, 10.1074/jbc.274.6.3700 · DOI
- Simental, 1991, Transcriptional activation and nuclear targeting signals of the human androgen receptor., J Biol Chem, 266, 510, 10.1016/S0021-9258(18)52466-2 · DOI · Paper page
- Gioeli, 2002, Androgen receptor phosphorylation: regulation and identificaton of the phosphorylation sites., J Biol Chem, 277, 29304, 10.1074/jbc.M204131200 · DOI · Paper page
- Weigel, 1996, Steroid hormone receptors and their regulation by phosphorylation., Biochem J, 319, 657, 10.1042/bj3190657 · DOI · Paper page
- Poukka, 2000, Covalent modification of the androgen receptor by small ubiquitin-like modifier 1(SUMO-1)., Proc Natl Acad Sci USA, 97, 14145, 10.1073/pnas.97.26.14145 · DOI · Paper page
- Schoenmakers, 1999, Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA binding domain., Biochem J, 341, 515, 10.1042/bj3410515 · DOI · Paper page
- Jenster, 1993, Nuclear import of the androgen receptor., Biochem J, 293, 761, 10.1042/bj2930761 · DOI · Paper page
- Zhou, 1994, A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor., J Biol Chem, 269, 13115, 10.1016/S0021-9258(17)36806-0 · DOI · Paper page
- Sheflin, 2000, Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels., Biochem Biophys Res Commun, 276, 144, 10.1006/bbrc.2000.3424 · DOI
- Rechsteiner, 1996, PEST sequences and regulation by proteolysis., Trends Biochem Sci, 21, 267, 10.1016/S0968-0004(96)10031-1 · DOI · Paper page
- Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor., Nature, 389, 753, 10.1038/39645 · DOI · Paper page
- Matias, 2000, Structural evidence for ligand specificity in the binding domain of the human androgen receptor., J Biol Chem, 275, 26164, 10.1074/jbc.M004571200 · DOI · Paper page
- Sack, 2001, Crystallographic structures of the ligand binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydroxytestosterone., Proc Natl Acad Sci USA, 98, 4904, 10.1073/pnas.081565498 · DOI · Paper page
- Williams, 1998, Atomic structure of progesterone complexed with its receptor., Nature, 393, 392, 10.1038/30775 · DOI · Paper page
- Bourguet, 2000, Nuclear receptor ligand binding domains: three-dimensional structures, molecular interactions and pharmacological implications., Trends Pharmacol Sci, 21, 381, 10.1016/S0165-6147(00)01548-0 · DOI · Paper page
- Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor gamma., Nature, 395, 137, 10.1038/25931 · DOI · Paper page
- Darimont, 1998, Structure and specificity of nuclear receptor-coactivator interactions., Genes Dev, 12, 3343, 10.1101/gad.12.21.3343 · DOI · Paper page
- McInerney, 1998, Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation., Genes Dev, 12, 3357, 10.1101/gad.12.21.3357 · DOI · Paper page
- Bevan, 1999, The AF-1 and AF-2 domains of the androgen receptor interact with distinct regions of SRC1., Mol Cell Biol, 19, 8383, 10.1128/MCB.19.12.8383 · DOI · Paper page
- Chang, 2002, Evaluation of ligand-dependent changes in AR structure using peptide probes., Mol Endocrinol, 16, 647, 10.1210/mend.16.4.0818 · DOI
- Wilson, 1996, A and B forms of the androgen receptor are expressed in a variety of human tissues., Mol Cell Endocrinol, 120, 51, 10.1016/0303-7207(96)03819-1 · DOI · Paper page
- Gao, 1998, Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists. Mol., Endcrinol, 12, 654, 10.1210/mend.12.5.0112 · DOI
- Conneely, 2001, Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice., Mol Cell Endocrinol, 179, 97, 10.1016/S0303-7207(01)00465-8 · DOI · Paper page
- Trapman, 1990, The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines. J., Steroid Biochem Mol Biol, 37, 837, 10.1016/0960-0760(90)90429-O · DOI
- Krongrad, 1991, Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells., Mol Cell Endocrinol, 76, 79, 10.1016/0303-7207(91)90262-Q · DOI · Paper page
- Wolf, 1993, Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen., Mol Endocrinol, 7, 924
- Zhou, 1995, Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability., Mol Endocrinol, 9, 208
- Wiren, 1997, Transcriptional up-regulation of the human androgen receptor by androgen in bone cells., Endocrinology, 138, 2291, 10.1210/endo.138.6.5163 · DOI
- Yu, 1995, Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas., J Hepatol, 22, 295, 10.1016/0168-8278(95)80282-7 · DOI
- Kerr, 1995, Distribution and hormonal regulation of androgen receptor (AR) and AR messinger ribonucleic acid in the rat hippocampus., Endocrinology, 136, 3213, 10.1210/endo.136.8.7628354 · doi:10.1210/endo.136.8.7628354 · Paper page
- Takeda, 1991, Autoreguation of androgen receptor expression in the rodent prostate: immunohistochemical and in situ hybridization analysis., Biochem Biophys Res Commun, 177, 488, 10.1016/0006-291X(91)92010-H · DOI
- Quarmby, 1990, Autologous down-regulation of androgen receptor messenger ribonucleic acid., Mol Endocrinol, 4, 22, 10.1210/mend-4-1-22 · DOI · Paper page
- Liao, 1965, Influence of testosterone on template activity of prostatic ribonucleic acids., J Biol Chem, 240, 1236, 10.1016/S0021-9258(18)97566-6 · doi:10.1016/s0021-9258(18)97566-6
- Takane, 1996, Functional analysis of the human androgen receptor promoter., Mol Cell Endocrinol, 119, 83, 10.1016/0303-7207(96)03800-2 · DOI
- Ren, 2000, Tea polyphenols down regulate the expression of the androgen receptor in LNCaP prostate cancer cells., Oncogene, 19, 1924, 10.1038/sj.onc.1203511 · DOI
- Mizokami, 1994, Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis acting elements in the human androgen receptor gene promoter., Mol Endocrinol, 8, 77
- Roeder, 1996, The role of general initiation factors in transcription by RNA polymerase II., Trends Biochem Sci, 21, 327, 10.1016/0968-0004(96)10050-5 · DOI · Paper page
- Pugh, 1991, Transcription from a TATA-less promoter requires a multisubunit TFIID complex., Gene Dev, 5, 1935, 10.1101/gad.5.11.1935 · DOI · Paper page
- Faber, 1991, Characterization of the human androgen receptor transcription unit., J Biol Chem, 266, 10743, 10.1016/S0021-9258(18)99080-0 · DOI
- Tilley, 1990, Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines., J Biol Chem, 265, 13776, 10.1016/S0021-9258(18)77416-4 · DOI
- Faber, 1993, Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen promoter: the role of Sp1., J Biol Chem, 268, 9296, 10.1016/S0021-9258(18)98349-3 · DOI
- Chen, 1997, Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with SP1 and a pyrimidine single strand binding protein., Mol Endocrinol, 11, 3, 10.1210/mend.11.1.9868 · DOI
- Lindzey, 1993, Regulation of the 5′-flanking region of the mouse androgen receptor gene by cAMP and androgen., Mol Endocrinol, 7, 1530
- Blok, 1992, Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types., Mol Cell Endocrinol, 88, 153, 10.1016/0303-7207(92)90020-7 · DOI
- Blok, 1992, Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein., Endocrinology, 131, 1343, 10.1210/endo.131.3.1324158 · doi:10.1210/endo.131.3.1324158
- Song, 1999, Negative regulation of the androgen receptor gene promoter by NF1 and an adjacently located multiprotein-binding site., Mol Endocrinol, 13, 1487, 10.1210/mend.13.9.0350 · DOI
- Supakar, 1993, A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene., J Biol Chem, 268, 26400, 10.1016/S0021-9258(19)74328-2 · DOI
- Supakar, 1995, Nuclear factor κB functions as a negative regulator for the rat androgen receptor gene and NF-κB activity increases during the age-dependent desensitization of the liver., J Biol Chem, 270, 837, 10.1074/jbc.270.2.837 · DOI
- Jarrard, 1998, Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells., Cancer Res, 58, 5310
- Esteller, 2001, A gene hypermethylation profile of human cancer., Cancer Res, 61, 97
- Sasaki, 2000, The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma., Mol Carcinog, 27, 237, 10.1002/(SICI)1098-2744(200003)27:3<237::AID-MC11>3.0.CO;2-0 · doi:10.1002/(sici)1098-2744(200003)27:3<237::aid-mc11>3.0.co;2-0
- Kinoshita, 2000, Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer., Cancer Res, 60, 3623
- Brandeis, 1994, Sp1 elements protect a CpG island from de novo methylation., Nature, 371, 435, 10.1038/371435a0 · DOI · Paper page
- Macleod, 1994, Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island., Genes Dev, 8, 2282, 10.1101/gad.8.19.2282 · DOI · Paper page
- Yeap, 1999, Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells., Endocrinology, 140, 3282, 10.1210/endo.140.7.6769 · DOI
- Mizokami, 1994, Induction of translation by the 5′-untranslated region of human androgen receptor mRNA., J Biol Chem, 269, 25655, 10.1016/S0021-9258(18)47299-7 · DOI
- Faber, 1991, The interaction of ubiquitous DNA-binding factors, availability of binding sites in the chromatin, and DNA methylation in the differential regulation of phosphoenol pyruvate carboxykinasse gene expression., Nucleic Acids Res, 19, 4681, 10.1093/nar/19.17.4681 · DOI
- Yeap, 2002, Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3′-untranslated region of the androgen receptor messenger RNA., J Biol Chem, 277, 27183, 10.1074/jbc.M202883200 · DOI
- Peng, 1998, RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein., EMBO J, 17, 3461, 10.1093/emboj/17.12.3461 · DOI · Paper page
- Chkheidze, 1999, Assembly of the β-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3′ untranslated region determinant and poly(C) binding protein CP., Mol Cell Biol, 19, 4572, 10.1128/MCB.19.7.4572 · DOI
- Ostareck, 1997, mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end., Cell, 89, 597, 10.1016/S0092-8674(00)80241-X · DOI · Paper page
- Hellwinkel, 2001, A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants., J Clin Endocrinol Metab, 86, 2569
- Lee, 1998, Proteasome inhibitors: valuable new tools for cell biologists., Trends Cell Biol, 8, 397, 10.1016/S0962-8924(98)01346-4 · DOI · Paper page
- Hershko, 1998, The ubiquitin system., Annu Rev Biochem, 67, 425, 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- Alarid, 1999, Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation., Mol Endocrinol, 13, 1522, 10.1210/mend.13.9.0337 · doi:10.1210/mend.13.9.0337 · Paper page
- El-Khissiin, 1999, Implication of proteasome in estrogen receptor degradation., FEBS Lett, 448, 160, 10.1016/S0014-5793(99)00343-9 · DOI
- Lonard, 2000, The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor transcription., Mol Cell, 5, 939, 10.1016/S1097-2765(00)80259-2 · DOI · Paper page
- Lange, 2000, Phosphorylation of human progesterone receptors a serine 294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome., Proc Natl Acad Sci USA, 97, 132, 10.1073/pnas.97.3.1032 · DOI · Paper page
- Tyagi, 2000, Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells., Mol Endocrinol, 14, 1162, 10.1210/mend.14.8.0497 · DOI · Paper page
- Gregory, 2001, Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen., Cancer Res, 61, 2892
- Koepp, 2001, Phosphorylation-dependent ubiquitination of cyclin E by SCFFbw7 ubiquitin ligase., Science, 294, 173, 10.1126/science.1065203 · DOI · Paper page
- Brown, 1995, Control of I kappa B-alpha proteolysis by site specific, signal induced phophorylation., Science, 267, 1485, 10.1126/science.7878466 · DOI · Paper page
- Brockman, 1995, Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation., Mol Cell Biol, 15, 2809, 10.1128/MCB.15.5.2809 · DOI · Paper page
- Lin, 2002, Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase., EMBO J, 21, 4037, 10.1093/emboj/cdf406 · DOI · Paper page
- Wen, 2000, Her2/neu promotes androgen independent survival and growth of prostate cancer cells through the Akt pathway., Cancer Res, 60, 6841
- Lin, 1998, Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines., J Biol Chem, 273, 5939, 10.1074/jbc.273.10.5939 · doi:10.1074/jbc.273.10.5939
- Merry, 2001, Molecular pathogenesis of spinal and bulba muscular atrophy., Brain Res Bull, 56, 203, 10.1016/S0361-9230(01)00594-9 · DOI
- Abdullah, 1998, Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolitically resistant in vitro and processed abnormally in transfected cells, Hum Mol Genet, 7, 379, 10.1093/hmg/7.3.379 · DOI
- Butler, 1998, Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy., Hum Mol Genet, 7, 121, 10.1093/hmg/7.1.121 · DOI
- Kahlem, 1996, Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking., Proc Natl Acad Sci USA, 93, 14580, 10.1073/pnas.93.25.14580 · DOI · Paper page
- Bailey, 2002, Molecular chaperones enhances the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulba muscular atrophy., Hum Mol Genet, 11, 515, 10.1093/hmg/11.5.515 · DOI · Paper page
- Ellerby, 1999, Kennedy’s disease: caspase cleavage of the androgen receptor is a critical event in cytotoxicity., J Neurochem, 72, 185, 10.1046/j.1471-4159.1999.0720185.x · DOI · Paper page
- Katsuno, 2002, Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy., Neuron, 35, 843, 10.1016/S0896-6273(02)00834-6 · DOI · Paper page
- Jemal, 2003, Cancer statistics., CA Cancer J Clin, 53, 5, 10.3322/canjclin.53.1.5 · DOI · Paper page
- Huggins, 1943, Studies on prostate cancer., Arch Surg, 43, 209, 10.1001/archsurg.1941.01210140043004 · DOI · Paper page
- Taplin, 1995, Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer., N Engl J Med, 332, 1393, 10.1056/NEJM199505253322101 · DOI · Paper page
- Miyamoto, 1998, Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate DU145 cells., Proc Natl Acad Sci USA, 95, 7379, 10.1073/pnas.95.13.7379 · DOI · Paper page
- McDonnell, 1992, Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer., Cancer Res, 52, 6940
- Raffo, 1995, Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen deprivation in vivo., Cancer Res, 55, 4438
- Lipponen, 1997, Expression of the apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy., Prostate, 32, 9, 10.1002/(SICI)1097-0045(19970615)32:1<9::AID-PROS2>3.0.CO;2-I · doi:10.1002/(sici)1097-0045(19970615)32:1<9::aid-pros2>3.0.co;2-i
- Aaltomaa, 1999, Prognostic value and expression of p21 protein in prostate cancer., Prostate, 39, 8, 10.1002/(SICI)1097-0045(19990401)39:1<8::AID-PROS2>3.0.CO;2-N · DOI
- Kuiper, 1989, Structural organization of the human androgen receptor gene, J Mol Endocrinol, 2, R2, 10.1677/jme.0.002R001 · DOI · Paper page
- Lubahn, 1989, Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity., Proc Natl Acad Sci USA, 86, 9534, 10.1073/pnas.86.23.9534 · DOI · Paper page
- Linja, 2001, Amplification and overexpression of androgen receptor gene in hormone refractory prostate cancer., Cancer Res, 61, 3550
- Miyoshi, 2000, Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients., Prostate, 43, 225, 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7 · doi:10.1002/(sici)1097-0045(20000515)43:3<225::aid-pros9>3.0.co;2-7
- Bubendorf, 1999, Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays., Cancer Res, 59, 803
- Edwards, 2001, Amplification of the androgen receptor may not explain the development of androgen independent prostate cancer., Br J Urol Int, 88, 633, 10.1046/j.1464-410X.2001.02350.x · DOI
- Gottlieb, 2001, Variable expressivity and mutation databases: the androgen receptor gene mutations database., Hum Mutat, 17, 382, 10.1002/humu.1113 · DOI
- Marcelli, 2000, Androgen receptor mutations in prostate cancer., Cancer Res, 60, 944
- Culig, 1993, Mutant androgen receptor detected in an advanced stage prostatic carcinoma is activated by adrenal androgens and progesterone., Mol Endocrinol, 7, 1541
- Zhao, 2000, Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor., Nat Med, 6, 703, 10.1038/76287 · DOI · Paper page
- Lee, 1995, Regulation of proliferation and production of PSA in androgen-sensitive prostate cancer cells, LNCaP, by DHT., Endocrinology, 136, 796, 10.1210/endo.136.2.7530653 · doi:10.1210/endo.136.2.7530653 · Paper page
- Yuan, 1993, Androgen-induced inhibition of cell proliferation in an androgen insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complimentary DNA., Cancer Res, 53, 13004
- Zhang, 2002, Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells., Proc Natl Acad Sci USA, 99, 7408, 10.1073/pnas.102014399 · DOI
- Mitchell, 1999, Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells., Cancer Res, 59, 5892
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Self-citationAndrogen-Induced Immunosuppression
Gubbels Bupp, M. R., & Jorgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 390
Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H.-J., Stehr, H., Rausch, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.002 · Cited by 320
Sinha-Hikim, I., Taylor, W. E., Gonzalez-Cadavid, N. F., Zheng, W., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0084 · Cited by 312
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Metadata
- Authors
- Lee, D. K., & Chang, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-09-01
- Volume
- 88
- Issue
- 9
- Pages
- 4043-4054
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2092714565
- Cited by
- 183
- References
- 12
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication. https://app.cochat.ai/papers/10.1210/jc.2003-030261
- The paper
- Lee, D. K., & Chang, C. (2003). Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-030261
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.